Smith & Nephew Past Earnings Performance
Past criteria checks 3/6
Smith & Nephew's earnings have been declining at an average annual rate of -18.5%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 3% per year. Smith & Nephew's return on equity is 5.9%, and it has net margins of 5.4%.
Key information
-18.5%
Earnings growth rate
-18.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 3.0% |
| Return on equity | 5.9% |
| Net Margin | 5.4% |
| Next Earnings Update | 25 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Smith & Nephew makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Jun 24 | 5,642 | 305 | 2,942 | 291 |
| 29 Mar 24 | 5,596 | 284 | 2,916 | 306 |
| 31 Dec 23 | 5,549 | 263 | 2,890 | 320 |
| 30 Sep 23 | 5,449 | 241 | 2,816 | 324 |
| 01 Jul 23 | 5,349 | 218 | 2,741 | 327 |
| 01 Apr 23 | 5,282 | 221 | 2,718 | 331 |
| 31 Dec 22 | 5,215 | 223 | 2,695 | 335 |
| 30 Sep 22 | 5,214 | 360 | 2,680 | 344 |
| 02 Jul 22 | 5,213 | 496 | 2,665 | 352 |
| 02 Apr 22 | 5,213 | 510 | 2,651 | 351 |
| 31 Dec 21 | 5,212 | 524 | 2,637 | 349 |
| 30 Sep 21 | 5,168 | 539 | 2,607 | 340 |
| 03 Jul 21 | 5,124 | 553 | 2,576 | 330 |
| 03 Apr 21 | 4,842 | 501 | 2,508 | 319 |
| 31 Dec 20 | 4,560 | 448 | 2,439 | 307 |
| 30 Sep 20 | 4,624 | 420 | 2,470 | 304 |
| 27 Jun 20 | 4,688 | 391 | 2,501 | 301 |
| 27 Mar 20 | 4,913 | 496 | 2,518 | 297 |
| 31 Dec 19 | 5,138 | 600 | 2,534 | 292 |
| 30 Sep 19 | 5,044 | 649 | 2,449 | 281 |
| 29 Jun 19 | 4,949 | 698 | 2,364 | 269 |
| 29 Mar 19 | 4,927 | 681 | 2,374 | 258 |
| 31 Dec 18 | 4,904 | 663 | 2,384 | 246 |
| 30 Sep 18 | 4,887 | 690 | 2,450 | 239 |
| 30 Jun 18 | 4,869 | 717 | 2,496 | 232 |
| 31 Mar 18 | 4,817 | 742 | 2,453 | 228 |
| 31 Dec 17 | 4,765 | 767 | 2,419 | 223 |
| 30 Sep 17 | 4,721 | 817 | 2,346 | 224 |
| 01 Jul 17 | 4,677 | 867 | 2,282 | 224 |
| 01 Apr 17 | 4,673 | 826 | 2,269 | 227 |
| 31 Dec 16 | 4,669 | 784 | 2,255 | 230 |
| 30 Sep 16 | 4,680 | 570 | 2,515 | 228 |
| 02 Jul 16 | 4,690 | 356 | 2,393 | 225 |
| 02 Apr 16 | 4,662 | 383 | 2,363 | 224 |
| 31 Dec 15 | 4,634 | 410 | 2,524 | 222 |
| 30 Sep 15 | 4,702 | 513 | 2,333 | 224 |
| 27 Jun 15 | 4,669 | 557 | 2,326 | 225 |
| 27 Mar 15 | 4,680 | 499 | 2,375 | 234 |
| 31 Dec 14 | 4,617 | 501 | 2,323 | 235 |
| 27 Sep 14 | 4,543 | 503 | 2,285 | 239 |
| 28 Jun 14 | 4,422 | 523 | 2,201 | 241 |
| 29 Mar 14 | 4,349 | 563 | 2,124 | 235 |
| 31 Dec 13 | 4,351 | 556 | 2,149 | 231 |
Quality Earnings: SNNU.F has a large one-off loss of $264.0M impacting its last 12 months of financial results to 29th June, 2024.
Growing Profit Margin: SNNU.F's current net profit margins (5.4%) are higher than last year (4.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SNNU.F's earnings have declined by 18.5% per year over the past 5 years.
Accelerating Growth: SNNU.F's earnings growth over the past year (39.9%) exceeds its 5-year average (-18.5% per year).
Earnings vs Industry: SNNU.F earnings growth over the past year (39.9%) exceeded the Medical Equipment industry 10.4%.
Return on Equity
High ROE: SNNU.F's Return on Equity (5.9%) is considered low.